HempNewsBreaks – Xanthic Biopharma Inc. Receives Conditional Listing Approval from the CSE

Xanthic Biopharma, a premium cannabinoid life sciences and technology company, recently announced that it has been granted conditional listing approval from the Canadian Securities Exchange (“CSE”) to list its common shares under the ticker symbol xTHC. The listing is subject to the successful completion of customary listing requirements of the CSE. The company has requested April 19th as its first trading date. “We are thrilled to begin trading on the CSE especially on the eve of ‘4/20’. We are excited to have obtained the ticker symbol xTHC, which we feel is memorable and readily connected with “Xanthic”. Our team would like to thank all of our supporters and current shareholders that have made this strategic milestone possible. We are excited to continue to develop and execute on Xanthic’s current vision and business model as we move forward,” Xanthic CEO Tim Moore stated in the news release.

To view the full press release, visit http://cnw.fm/TgA9W

About Xanthic

Xanthic, through its wholly-owned operating subsidiary, Xanthic Biopharma Limited, provides valuable intellectual property to cannabis industry participants, enabling its strategic partners to produce high quality, innovative, non-combustible cannabis, and cannabis-infused products which deliver consistent THC and/or CBD levels. Using a proprietary process, Xanthic allows its strategic partners to deliver superior cannabinoid solubility and consistency versus competitive infused products. For more information, visit the company’s website at www.XanthicBio.com.

More from CannabisNewsBreaks

• HempNewsBreaks – CannabisNewsWire Named Official Newswire of 2025 Cannabis Means Business Expo in NYC 
• HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 
• HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net